In pancreatic cancer, doxycycline showed to affect PC growth by activating proapoptotic genes and suppressing antiapoptotic genes, perturbating cell cycle and inhibiting the expression of the proangiogenic IL-8 [34,35]. The gene discussed is CXCL8; the disease is pancreatic neoplasm.